First PrEP In China: Gilead Faces Changing Market For Truvada
Generics Loom For Treatment Use
Executive Summary
The China approval of Gilead’s Truvada in a new indication brings up a familiar question: how soon will domestic generics take over a new market with large potential amid a fast-changing environment?